Schedule 13G ownership disclosure
TSCAN THERAPEUTICS INC
Security class unavailable · CUSIP: 89854M101
Event date: 2023-05-26
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-23-001429
- Form type
- SC 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Jun 05, 2023
- Reporting period
- May 26, 2023
- Description
- Schedule 13G beneficial ownership